We are delighted to have you join us at the 2nd Annual Texas Lung Cancer Conference in Austin, Texas, at the historic rock and roll landmark, ACL Live at The Moody Theater. This conference is co-chaired by Dr. Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C., and Dr. Tina Cascone, Associate Professor of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Clinical management of lung cancer has become increasingly complex – reflecting the transformative benefits we see with immunotherapy and targeted therapy. This two-day CE-event will review the latest advances in lung cancer and other thoracic malignancies with an emphasis on what every oncologist needs to know to provide state-of-the-art care today. We have assembled a roster of the top lung cancer researchers in the country, all of whom are approachable, energetic, and engaging experts. This conference is appropriate for all levels of training and experience. Sessions will cover a variety of topics, including multimodal approaches for operable lung cancer, controversies in immunotherapy, innovations in targeted therapy and the proper use of liquid biopsy, among others. The conference will also feature a debate on the competing neoadjuvant and perioperative immunotherapy strategies for non-small cell lung cancer and a poster competition with a travel award for trainees and junior faculty.

The Texas Lung Cancer Conference is more than a rehash of the available data – it is an opportunity to understand the reasoning behind the clinical trials and the best approach to patient care. Thank you for joining us at the inaugural Texas Lung Cancer Conference in Austin, The Live Music Capital of the World.